DeliNova Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$14.7M
- Investors
-
8
DeliNova Therapeutics General Information
Description
Developer of in vivo CAR-T therapies designed for the treatment of cancer and autoimmune diseases. The company offers engineered viral vectors and T-cell-specific delivery platforms, enabling healthcare providers to deliver cell therapies directly within the patient's body to reduce treatment costs and preparation time.
Contact Information
Corporate Office
- Number 60, Xiaohai Street
- Development Zone
- Nantong, Jiangsu 200000
- China
Corporate Office
- Number 60, Xiaohai Street
- Development Zone
- Nantong, Jiangsu 200000
- China
DeliNova Therapeutics Timeline
DeliNova Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 10-Jun-2026 | $14.7M | Completed | Generating Revenue | ||
| 2. Seed Round | 22-Sep-2025 | Completed | Startup | |||
| 1. Seed Round | 03-Jul-2025 | Completed | Startup |
DeliNova Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Gage Capital | Asset Manager | Minority | ||
| In Capital | Venture Capital | Minority | ||
| Proxima Capital | Venture Capital | Minority | ||
| CAS Star | Venture Capital | Minority | ||
| Hongfeng Capital | Growth/Expansion | Minority |
DeliNova Therapeutics FAQs
-
When was DeliNova Therapeutics founded?
DeliNova Therapeutics was founded in 2025.
-
Where is DeliNova Therapeutics headquartered?
DeliNova Therapeutics is headquartered in Nantong, China.
-
What industry is DeliNova Therapeutics in?
DeliNova Therapeutics’s primary industry is Drug Discovery.
-
Is DeliNova Therapeutics a private or public company?
DeliNova Therapeutics is a Private company.
-
What is DeliNova Therapeutics’s current revenue?
The current revenue for DeliNova Therapeutics is .
-
How much funding has DeliNova Therapeutics raised over time?
DeliNova Therapeutics has raised $23.1M.
-
Who are DeliNova Therapeutics’s investors?
Beijing Gage Capital, In Capital, Proxima Capital, CAS Star, and Hongfeng Capital are 5 of 8 investors who have invested in DeliNova Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process